Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...
LIXTE Biotechnology (LIXT) announced the closing of its previously announced registered direct offering priced at-the-market ...
Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...
LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...
Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning Virginia as a leader in biotechnology. Virginia Tech, Carilion Clinic, and the ...
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One ...
The Modesto Bee on MSN3h
From fashion to finance, Modesto high schools offer over a dozen career and technical pathsAll high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...
Prime Minister Narendra Modi met Indian-American entrepreneur Vivek Ramaswamy in Washington to discuss India-US relations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback